NGVT earnings: next report 2026-07-29, real EPS beat/miss history, analyst consensus Buy, P/E -21.34. Updated 2026-07-23.
Ingevity (NGVT) Research Hub
Ingevity (NGVT) trades on NYSE, US in the Basic Materials (Chemicals - Specialty) sector. As of 2026-09-11, shares last closed at 69.41 USD (+1.92%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -21.34, market cap 2.60B. This hub links to the full technical, earnings and options research available for NGVT.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Basic Materials (Chemicals - Specialty) |
|---|---|
| Exchange | NYSE, US |
| Last close | 69.41 USD (+1.92%) |
| 52-week range | 67.28 USD – 79.05 USD |
| Trend regime | Range |
| 14-day RSI | 25.3 (Oversold) |
| Trailing P/E | -21.34 |
| Market cap | 2.60B |
| Dividend yield | 0.00% |
| Next earnings | 2026-07-29 |
Available research for NGVT
Covered Call on NGVT: how it works, illustrative setup around the real 69.41 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on NGVT: how it works, illustrative setup around the real 69.41 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on NGVT: how it works, illustrative setup around the real 69.41 USD price, max profit/loss, breakeven and when to use it. Educational.
NGVT technical analysis: range, last 69.41 USD, RSI 25.3, 52w range 67.28 USD–79.05 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is NGVT in?
Ingevity (NGVT) is classified under Basic Materials (Chemicals - Specialty), listed on NYSE, US.
Is NGVT in an uptrend or downtrend?
As of 2026-09-11, NGVT is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is NGVT's trailing P/E ratio?
NGVT's trailing P/E is -21.34, with a market cap of 2.60B. See the earnings research page for full valuation detail.
When does NGVT next report earnings?
NGVT is next scheduled to report earnings on 2026-07-29, with a consensus EPS estimate of 1.31 USD.